Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Long-Term Investments (2021 - 2025)

Zymeworks' Long-Term Investments history spans 3 years, with the latest figure at $95.7 million for Q3 2023.

  • For Q3 2023, Long-Term Investments rose 10698.42% year-over-year to $95.7 million; the TTM value through Sep 2023 reached $95.7 million, up 10698.42%, while the annual FY2022 figure was $886000.0, 0.0% changed from the prior year.
  • Long-Term Investments for Q3 2023 was $95.7 million at Zymeworks, up from $92.2 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $95.7 million in Q3 2023 and bottomed at $886000.0 in Q4 2021.
  • The 3-year median for Long-Term Investments is $36.7 million (2021), against an average of $43.8 million.
  • The largest annual shift saw Long-Term Investments changed 0.0% in 2022 before it skyrocketed 10698.42% in 2023.
  • A 3-year view of Long-Term Investments shows it stood at $886000.0 in 2021, then changed by 0.0% to $886000.0 in 2022, then surged by 10698.42% to $95.7 million in 2023.
  • Per Business Quant, the three most recent readings for ZYME's Long-Term Investments are $95.7 million (Q3 2023), $92.2 million (Q2 2023), and $72.5 million (Q1 2023).